Skip to Content

Anika Therapeutics Inc ANIK

Morningstar Rating
$25.31 +0.31 (1.24%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ANIK is trading at a 31% discount.
Price
$25.06
Fair Value
$65.28
Uncertainty
Very High
1-Star Price
$21.57
5-Star Price
$35.26
Economic Moat
Txpf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ANIK is a good fit for your portfolio.

Trading Information

Previous Close Price
$25.00
Day Range
$24.9725.43
52-Week Range
$16.5428.87
Bid/Ask
$25.31 / $26.53
Market Cap
$375.85 Mil
Volume/Avg
37,432 / 84,757

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.27
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
1.30%

Company Profile

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
357

Comparables

Valuation

Metric
ANIK
NARI
ATEC
Price/Earnings (Normalized)
462.73
Price/Book Value
1.795.3525.42
Price/Sales
2.274.953.59
Price/Cash Flow
36.6973.45
Price/Earnings
ANIK
NARI
ATEC

Financial Strength

Metric
ANIK
NARI
ATEC
Quick Ratio
3.502.431.86
Current Ratio
5.263.092.86
Interest Coverage
−56.99−10.23
Quick Ratio
ANIK
NARI
ATEC

Profitability

Metric
ANIK
NARI
ATEC
Return on Assets (Normalized)
−1.35%5.07%−9.89%
Return on Equity (Normalized)
−1.65%6.37%
Return on Invested Capital (Normalized)
−2.24%3.35%−9.94%
Return on Assets
ANIK
NARI
ATEC
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncHssvlgzjtBkwx$136.4 Bil
BDX
Becton Dickinson & CoCvlhwblwxCbhcvx$67.9 Bil
ALC
Alcon IncBwkdgtwrZlvvqxt$40.4 Bil
CLPBY
Coloplast A/S ADRGltnmxcjVrgy$29.3 Bil
WST
West Pharmaceutical Services IncXxxgrhvhzRsjb$28.5 Bil
RMD
ResMed IncRnwmtdfblqYzxnvn$27.2 Bil
BAX
Baxter International IncWtpykhyRqdmn$20.4 Bil
COO
The Cooper Companies IncVzqqvtdlMcfmqk$18.3 Bil
HOLX
Hologic IncXrfqzrnjlJqnmyy$18.2 Bil
TFX
Teleflex IncVqqSddl$9.9 Bil

Sponsor Center